title: Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation.
authors.forename: Lauren M
authors.initials: LM
authors.lastname: Dunford
authors.forename: David M
authors.initials: DM
authors.lastname: Roy
authors.forename: Theresa E
authors.initials: TE
authors.lastname: Hahn
authors.forename: Swaminathan
authors.initials: S
authors.lastname: Padmanabhan
authors.forename: Brahm H
authors.initials: BH
authors.lastname: Segal
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Almyroudis
authors.forename: Philip L
authors.initials: PL
authors.lastname: McCarthy
authors.forename: Minoo
authors.initials: M
authors.lastname: Battiwalla
mesh_terms: D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications / Q000628:therapy; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced*; D016720:Pneumocystis Infections / Q000517:prevention & control*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000628:therapy; D014184:Transplantation, Homologous
chemical_list: D000890:Anti-Infective Agents; D003622:Dapsone